AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Krametter, D Niederwieser, G Berghold, A Birnbaum, G Strasser-Fuchs, S Hartung, HP Archelos, JJ
Citation: D. Krametter et al., Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker, MULT SCLER, 7(1), 2001, pp. 13-18

Authors: Yan, WX Archelos, JJ Hartung, HP Pollard, JD
Citation: Wx. Yan et al., P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy, ANN NEUROL, 50(3), 2001, pp. 286-292

Authors: Krametter, D Niederwieser, G Berghold, A Birnbaum, G Strasser-Fuchs, S Hartung, HP Archelos, JJ
Citation: D. Krametter et al., Chlamydia pneumoniae-specific humoral immune responses and clinical disease parameters in multiple sclerosis, ANN NEUROL, 49(1), 2001, pp. 135-135

Authors: Previtali, SC Feltri, ML Archelos, JJ Quattrini, A Wrabetz, L Hartung, HP
Citation: Sc. Previtali et al., Role of integrins in the peripheral nervous system, PROG NEUROB, 64(1), 2001, pp. 35-49

Authors: Archelos, JJ Hartung, HP
Citation: Jj. Archelos et Hp. Hartung, Demyelinating antibodies in multiple sclerosis - Reply, ANN NEUROL, 48(6), 2000, pp. 948-948

Authors: Archelos, JJ Storch, MK Hartung, HP
Citation: Jj. Archelos et al., The role of B cells and autoantibodies in multiple sclerosis, ANN NEUROL, 47(6), 2000, pp. 694-706

Authors: Schuld, A Archelos, JJ Friess, E
Citation: A. Schuld et al., Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: Is the sigma receptor involved?, J CL PSYCH, 20(5), 2000, pp. 579-580

Authors: Archelos, JJ Hartung, HP
Citation: Jj. Archelos et Hp. Hartung, Pathogenetic role of autoantibodies in neurological diseases, TRENDS NEUR, 23(7), 2000, pp. 317-327

Authors: Kieseier, BC Storch, MK Archelos, JJ Martino, G Hartung, HP
Citation: Bc. Kieseier et al., Effector pathways in immune mediated central nervous system demyelination, CURR OP NEU, 12(3), 1999, pp. 323-336

Authors: Gold, R Archelos, JJ Hartung, HP
Citation: R. Gold et al., Mechanisms of immune regulation in the peripheral nervous system, BRAIN PATH, 9(2), 1999, pp. 343-360

Authors: Wewetzer, K Archelos, JJ Hartung, HP Seilheimer, B Christ, B
Citation: K. Wewetzer et al., The monoclonal antibody 23E9 defines a novel developmentally-regulated Schwann cell surface antigen, INT J DEV N, 17(7), 1999, pp. 715-725

Authors: Archelos, JJ Previtali, SC Hartung, HP
Citation: Jj. Archelos et al., The role of integrins in immune-mediated diseases of the nervous system, TRENDS NEUR, 22(1), 1999, pp. 30-38

Authors: Sindou, P Vallat, JM Chapon, F Archelos, JJ Tabaraud, F Anani, T Braund, KG Maisonobe, T Hauw, JJ Vandenberghe, A
Citation: P. Sindou et al., Ultrastructural protein zero expression in Charcot-Marie-Tooth type 1B disease, MUSCLE NERV, 22(1), 1999, pp. 99-104

Authors: Kieseier, BC Archelos, JJ Storch, M Gold, R Hartung, HP
Citation: Bc. Kieseier et al., The immunopathogenesis of multiple sclerosis - A survey of recent advancesand implications for future therapy, WIEN KLIN W, 111(17), 1999, pp. 728-737

Authors: Archelos, JJ Hartung, HP
Citation: Jj. Archelos et Hp. Hartung, Adhesion molecules in multiple sclerosis: a review, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 85-116
Risultati: 1-15 |